Haojun Chen
Impact in
- Oncology top 0.5%
- Peptidase Inhibition and Analysis
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms
Papers in
- Oncology 101
- Peptidase Inhibition and Analysis 80
- Cancer Immunotherapy and Biomarkers 11
- Lung Cancer Research Studies 8
-
- Protease and Inhibitor Mechanisms 46
Haojun Chen
129 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 2.7k
- Cancer Research 1.4k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Surgery 1.4k
- Cellular and Molecular Neuroscience 503
Countries citing papers authored by Haojun Chen
This map shows the geographic impact of Haojun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haojun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haojun Chen more than expected).
Fields of papers citing papers by Haojun Chen
This network shows the impact of papers produced by Haojun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haojun Chen. The network helps show where Haojun Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haojun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 13 | |
| 5 | 2025 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 11 | |
| 9 | 2024 | 4 | |
| 10 | 2023 | 56 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 6 | |
| 14 | 2022 | 46 | |
| 15 | 2020 | 24 | |
| 16 | 2020 | 197 | |
| 17 | 2019 | 8 | |
| 18 | 2017 | 25 | |
| 19 | 2015 | 26 | |
| 20 | The role of bridge sequence in the construction of artificial ribozyme M1GS | 2005 | 0 |
About Haojun Chen
Haojun Chen is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Surgery and Immunology and Allergy, having authored 135 papers that have together received 3.7k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (80 papers), Protease and Inhibitor Mechanisms (46 papers), Cardiac Structural Anomalies and Repair (32 papers), Radiopharmaceutical Chemistry and Applications (27 papers), Neuropeptides and Animal Physiology (14 papers), Medical Imaging Techniques and Applications (11 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (1.4k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations), Surgery (1.4k citations) and Cellular and Molecular Neuroscience (503 citations). Haojun Chen has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Yizhen Pang, Liang Zhao, Long Sun, Hua Wu, Qin Lin, Xiaohong Chen, Bing Hao, Hua Wu, Gang Niu and Zuoming Luo. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, Theranostics, Radiology and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.